Ziprasidone alternative for olanzapine-induced hyperglycemia.
Spivak
Baruch
B
Alamy
Sayed S
SS
Jarskog
L Fredrik
LF
Sheitman
Brian B
BB
Lieberman
Jeffrey A
JA
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001569:Benzodiazepines; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced*; D008297:Male; D000077152:Olanzapine; D010879:Piperazines / Q000627:therapeutic use*; D010890:Pirenzepine / Q000009:adverse effects* / Q000031:analogs & derivatives / Q000627:therapeutic use; D012563:Schizophrenia, Paranoid / Q000188:drug therapy*; D013844:Thiazoles / Q000627:therapeutic use*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D010879:Piperazines; D013844:Thiazoles; D001569:Benzodiazepines; D010890:Pirenzepine; C092292:ziprasidone; D000077152:Olanzapine